Safety Comparison: Making an Informed Switch Decision
Which is Safer Wegovy or Mounjaro: Understanding the Key Differences
When evaluating which is safer between Wegovy or Mounjaro, it's essential to understand their distinct mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural fullness hormone, whilst Mounjaro contains tirzepatide, which targets both GLP-1 and GIP receptors as a dual agonist. Both are prescription-only medicines that require clinical assessment and ongoing monitoring. The safety profile of each medication has been established through extensive clinical trials, with both demonstrating similar common side effects including nausea, vomiting, and gastrointestinal discomfort, particularly during dose escalation phases.
Patients often switch between these medications based on individual tolerance, availability, or cost considerations rather than significant safety differences. Both Wegovy and Mounjaro are available from EverydayMeds, allowing your prescriber to help determine which is right for your specific circumstances. Our GPhC-registered pharmacy (#9012878) ensures both medications are dispensed with full clinical oversight and proper cold-chain handling. The decision of which is safer between Wegovy or Mounjaro ultimately depends on your individual medical history, current medications, and how well you tolerate each treatment alongside a reduced-calorie diet and increased physical activity.
Wegovy vs Mounjaro Pricing: Switch and Save Opportunities
Understanding the cost implications when considering which is safer between Wegovy or Mounjaro helps inform your switching decision. Wegovy pricing at EverydayMeds starts with the 0.25mg starter dose at £79.99, progressing through 0.5mg at £94.99, 1mg at £99.99, 1.7mg at £139.99, to the maintenance 2.4mg dose at £209.99. Our Getting Started bundles provide convenient dose progression, such as the Intro Duo (0.25mg & 0.5mg) for £169.99 or the Progress Trio (0.5mg, 1mg & 1.7mg) for £369.99. New customers can apply discount code FIRST40 at checkout, whilst returning customers use code DOSE25 for additional savings.
When switching between medications, patients often find cost considerations influence their decision alongside safety factors. Our Ultimate Stability Trio provides three months of maintenance 2.4mg supply for £649.99, offering supply security for established patients. The 3-minute online clinical assessment ensures switching is clinically appropriate, with prescriber review typically completed within 3 working days (or 24 hours with express service). Both medications require the same commitment to lifestyle changes, making cost comparison a practical consideration when determining which treatment suits your long-term weight management goals.
Clinical Evidence: Wegovy Safety Profile in STEP Trials
The safety profile for Wegovy has been extensively studied in the STEP clinical trial programme, with data from Wilding et al., NEJM, 2021, demonstrating its safety alongside efficacy. In clinical trials, patients taking Wegovy alongside diet and exercise experienced common side effects including nausea, vomiting, diarrhoea, and constipation, particularly during the initial dose escalation period. Most gastrointestinal side effects were mild to moderate in severity and decreased over time as patients adjusted to treatment.
The STEP trials also evaluated cardiovascular safety, with the subsequent SELECT trial showing a 20% reduction in major cardiovascular events. When comparing which is safer between Wegovy or Mounjaro, both medications have undergone rigorous safety evaluation, though head-to-head safety comparisons aren't available due to different trial designs and populations. Patients switching between treatments should maintain close contact with their prescriber to monitor for any adverse effects during the transition period.
How Wegovy Works: GLP-1 Mechanism and Safety Considerations
Wegovy works as a GLP-1 receptor agonist, mimicking a natural hormone called glucagon-like peptide-1 that your body produces after eating. This mechanism reduces appetite by signalling fullness to your brain, promoting satiety after smaller meals, and potentially reducing food cravings by working on brain appetite centres. The once-weekly injection using the FlexTouch pen device provides consistent medication levels, which many patients find more convenient than daily treatments. Understanding this mechanism helps patients appreciate why certain side effects occur, particularly the gastrointestinal effects that result from slowed gastric emptying. The safety profile reflects this mechanism of action, with most side effects being related to the digestive system and typically improving as your body adjusts to treatment over several weeks.
EverydayMeds Ordering Process: Safe Switching Support
Our streamlined ordering process ensures safe switching between weight management medications through comprehensive clinical oversight. The 3-minute online clinical assessment captures your medical history, current medications, and reasons for switching to help prescribers evaluate the safest transition approach. Following submission, our qualified prescribers review your assessment within 3 working days (or 24 hours with express service), considering factors like your previous treatment response and any side effects experienced. Once approved, your Wegovy is dispatched via next-day delivery using temperature-controlled cold-chain packaging to maintain medication integrity. Our GPhC-registered pharmacy (#9012878) ensures full compliance with UK prescribing regulations throughout the switching process, providing ongoing support as you transition between treatments.
Storage and Practical Advantages: Wegovy vs Mounjaro Comparison
When considering which is safer between Wegovy or Mounjaro, practical factors like storage requirements can influence your decision. Wegovy must be stored in the fridge at 2-8°C before first use but can be kept at room temperature below 30°C for up to 6 weeks once removed, compared to Mounjaro's 21-day room temperature limit. This storage advantage makes Wegovy more convenient for travel or situations where refrigeration isn't consistently available. Both medications use pre-filled injection pens, but the FlexTouch pen design for Wegovy is familiar to many patients who may have used other Novo Nordisk products. The mandatory dose escalation schedule for Wegovy (0.25mg, 0.5mg, 1mg, 1.7mg, then 2.4mg maintenance) helps minimise side effects by allowing your body to gradually adjust to increasing doses over 16 weeks before reaching the therapeutic maintenance level.
Which is Safer Wegovy or Mounjaro: Individual Response Factors
The question of which is safer between Wegovy or Mounjaro often comes down to individual patient factors rather than absolute safety differences. Some patients switch from Mounjaro to Wegovy due to better tolerance of gastrointestinal side effects, whilst others may find Wegovy's single-target GLP-1 mechanism more suitable than Mounjaro's dual-target approach. Your medical history, including conditions like gastroparesis, pancreatitis history, or kidney function, may influence which medication your prescriber considers safer for your circumstances. Both medications carry similar contraindications and require careful monitoring, particularly during the initial months of treatment.
Age, concurrent medications, and lifestyle factors all contribute to determining the safest choice for individual patients. Patients with established type 2 diabetes may have different risk-benefit considerations compared to those using weight management medication alone. The switching process should always involve prescriber guidance, as direct transitions between medications may require specific timing and dose adjustments to maintain safety whilst minimising treatment gaps that could affect your weight management progress.
Start Your Safe Switch to Wegovy Today
Ready to explore whether Wegovy might be the safer choice for your weight management journey? Our clinical team is available to support your switching decision with comprehensive assessment and ongoing monitoring. New customers can use discount code FIRST40 at checkout, whilst returning customers apply code DOSE25 for additional savings on their prescription-only medicine. Visit our weight loss collection at https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment today. With next-day delivery and full prescriber support, EverydayMeds makes switching between weight management treatments straightforward and clinically safe. Both Wegovy and Mounjaro are available from our GPhC-registered pharmacy, ensuring you have access to the treatment that's right for your individual circumstances and safety profile.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
